Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Intra-anal Nifedipine, Used As Add-on to Conservative Therapy, on Pain in Patients With Anal Fissure

NCT02527109 is registered in ClinicalTrials.gov with RDD Pharma Ltd as lead sponsor.

NCT NCT02527109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02527109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Intra-anal Nifedipine, Used As Add-on to Conservative Therapy, on Pain in Patients With Anal Fissure
Lead sponsor
RDD Pharma Ltd
Phase
Phase 2/3
Overall status
Completed
Start date
May 31, 2016
Completion date
August 22, 2018
Enrollment
339 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

chronic anal fissure